Scientific article
Open access

Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study

Published inSupportive care in cancer, vol. 16, no. 7, p. 847-852
  • Open Access - Licence nationale Springer
Publication date2008

GOALS: The objective of this study was to determine utility of prophylactic anti-coagulation in cancer patients hospitalised for palliative care in a specialised centre. MATERIALS AND METHODS: Prospective 1:1 open randomised study was designed. Twenty patients aged 55 to 88 years with advanced cancer and an estimated life expectancy of less than 6 months were assigned to either receive treatment with 2,850/3,800 U (<70/>70 kg) of daily subcutaneous nadroparin or no treatment. Suspicion of venous thrombo-embolism (deep vein thrombosis and pulmonary embolism) was confirmed by echo-Doppler examination of the lower limbs and/or by spiral computed tomography scan of the lungs. Bleeding episodes were recorded. Platelet count was measured on days 7 and 14. Survival time from study entry was determined. MAIN RESULTS: One venous thrombo-embolism and one major bleeding occurred in the group receiving nadroparin, whereas two minor bleedings occurred in the control group. At 3 months, nine of ten participants had died in the control group vs five of ten in the group receiving nadroparin (P = 0.141). Five participants could be discharged home (P = 0.141). CONCLUSIONS: Decision to administer prophylactic nadroparin in hospitalised cancer patients under palliative care remains a challenge. Better mobility score at admission and the likelihood to be discharged home may be useful for practical purposes. The observation of a potential influence of prophylactic nadroparin on survival deserves further studies.

  • Aged
  • Aged 80 and over
  • Anticoagulants/therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nadroparin/therapeutic use
  • Neoplasms/complications/mortality/pathology/physiopathology
  • Palliative Care/methods
  • Prospective Studies
  • Survival
  • Venous Thromboembolism/prevention & control/ultrasonography
Citation (ISO format)
WEBER, Catherine et al. Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study. In: Supportive care in cancer, 2008, vol. 16, n° 7, p. 847–852. doi: 10.1007/s00520-007-0339-3
Main files (1)
Article (Published version)
ISSN of the journal0941-4355

Technical informations

Creation02/17/2009 11:28:00 AM
First validation02/17/2009 11:28:00 AM
Update time03/14/2023 3:00:38 PM
Status update03/14/2023 3:00:38 PM
Last indexation10/18/2023 10:11:11 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack